Driver of cystic fibrosis lung inflammation yields target for treatment
Yale researchers have identified a possible driver of the persistent inflammation that causes irreversible lung damage in patients with cystic fibrosis, a genetic disorder that impairs breathing and digestion.
Dec 13, 2022
0
102